Keyword: psoriasis treatment
News
09.03.2016
- US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...
News
29.01.2016
- The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...
News
04.09.2015
- Canadian drugmaker Valeant has said it will work with AstraZeneca on a potential treatment for psoriasis, brodalumab, taking up the gauntlet from Amgen, which recently curtailed...
News
28.10.2012
- Merck & Co posted a higher-than-expected quarterly profit as one-time tax gains helped offset plunging sales of its former flagship product, Singulair, an asthma drug that began...
